{"title": "Prophylaxe und Therapie bei h\u00e4mato-onkologischen Patienten", "author": "SAEZ Schweizerische \u00c4rztezeitung; Dr med Nando Bloch; Prof Dr med Werner C Albrich; MSCR", "url": "https://saez.swisshealthweb.ch/de/article/doi/saez.2023.21903", "hostname": "swisshealthweb.ch", "description": null, "sitename": "Dr. med. Nando Bloch,Prof. Dr. med. Werner C. Albrich,MSCR", "date": "2023-06-28", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "1 Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. August 2020;584(7821):430\u20136.\n2 Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, et al. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges. Theranostics. 2021;11(2):731\u201353.\n3 Arcani R, Colle J, Cauchois R, Koubi M, Jarrot PA, Jean R, et al. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue. Ann Hematol. November 2021;100(11):2799\u2013803.\n4 Lee LYW, Cazier JB, Starkey T, Briggs SEW, Arnold R, Bisht V, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. Oktober 2020;21(10):1309\u201316.\n5 Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, M\u00f8ller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. Juli 2022;22(7):967\u201376.\n6 Pinato DJ, Aguilar-Company J, Ferrante D, Hanbury G, Bower M, Salazar R, et al. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. Lancet Oncol. Juli 2022;23(7):865\u201375.\n7 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2. M\u00e4rz 2022;376:e068632.\n8 Su E, S Fischer, R Demmer-Steingruber, Nigg S, G\u00fcsewell S, Albrich WC, et al. Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment. ESMO Open. Oktober 2022;7(5):100587.\n9 Fendler A, Shepherd STC, Au L, Wu M, Harvey R, Schmitt AM, et al. Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer. Lancet Lond Engl. 5. M\u00e4rz 2022;399(10328):905\u20137.\n11 Collier ARY, Miller J, Hachmann NP, McMahan K, Liu J, Bondzie EA, et al. Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters. N Engl J Med. 9. Februar 2023;388(6):565\u20137.\n12 Davis-Gardner ME, Lai L, Wali B, Samaha H, Solis D, Lee M, et al. Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster. N Engl J Med. 12. Januar 2023;388(2):183\u20135.\n13 Johnson AG, Linde L, Ali AR, DeSantis A, Shi M, Adam C, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged \u226512 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022. MMWR Morb Mortal Wkly Rep. 10. Februar 2023;72(6):145\u201352.\n14 Imai M, Ito M, Kiso M, Yamayoshi S, Uraki R, Fukushi S, et al. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB. N Engl J Med. 5. Januar 2023;388(1):89\u201391.\n15 Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med. 14. April 2022;386(15):1397\u2013408.\n16 Dryden-Peterson S, Kim A, Kim AY, Caniglia EC, Lennes IT, Patel R, et al. Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System: A Population-Based Cohort Study. Ann Intern Med. Januar 2023;176(1):77\u201384.\n17 Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N Engl J Med. 27. Januar 2022;386(4):305\u201315.\n18 Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 10. Februar 2022;386(6):509\u201320.\n19 Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. Lancet Lond Engl. 8. Oktober 2022;400(10359):1213\u201322.\n20 Malone B, Campbell EA. Molnupiravir: coding for catastrophe. Nat Struct Mol Biol. September 2021;28(9):706\u20138.", "language": null, "image": null, "pagetype": "article", "links": ["https://www.swisshealthweb.ch/de/newsfeed/", "https://saez.swisshealthweb.ch/de/", "#collapseSearch", "/de/article/doi/saez.2023.21903/", "/fr/article/doi/bms.2023.21903/", "https://www.swisshealthweb.ch/de/newsfeed/", "https://saez.swisshealthweb.ch/de/", "/de/", "/de/aktuelle-ausgabe/", "/de/archiv/", "/de/publizieren/", "/de/ueber-saez/", "https://www.swisshealthweb.ch/de/zeitschriften/", "https://shop.emh.ch/", "https://www.swisshealthweb.ch/de/encyclomed/", "https://events.emh.ch", "https://saez.swisshealthweb.ch/de/article/?tx_cs2services_teaser%5Baction%5D=serviceLinkHandler&tx_cs2services_teaser%5Bcontroller%5D=Services&tx_cs2services_teaser%5Bservice%5D=9&type=96529&cHash=712c3da46ac560374a1cc72a483b3efd", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "/de/article/doi/saez.2023.21903/", "/fr/article/doi/bms.2023.21903/", "https://events.emh.ch/", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", "https://shop.emh.ch/", null, "javascript:void(0)", "https://saez.swisshealthweb.ch/fileadmin/assets/SAEZ/2023/saez.2023.21903/saez-2023-21903.pdf", "#otherInfos", "/de/archiv/ausgabe/issue-doi/saez.2023.26/", "https://doi.org/10.4414/saez.2023.21903", "javascript:void(0)", "https://saez.swisshealthweb.ch/fileadmin/assets/SAEZ/2023/saez.2023.21903/saez-2023-21903.pdf", "https://www.bag.admin.ch/bag/de/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/information-fuer-die-aerzteschaft/covid-19-impfung.html", "https://emh.ch/en/emh/rights-and-licences/", "#top", null, null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "https://www.swisshealthweb.ch/de/informationen-und-services/qualitaetssicherung/", "https://www.swisshealthweb.ch/de/informationen-und-services/publizistische-leitlinien/", "https://www.swisshealthweb.ch/de/informationen-und-services/copyright/", "https://www.swisshealthweb.ch/de/informationen-und-services/newsletter/", "https://www.swisshealthweb.ch/de/verlag/ueber-emh/", "https://www.swisshealthweb.ch/de/verlag/inserieren/", "https://www.swisshealthweb.ch/de/verlag/jobs/", "https://www.swisshealthweb.ch/de/partner/", "https://www.swisshealthweb.ch/de/verlag/hilfe-und-kontakt/", "https://www.swisshealthweb.ch/de/agb/", "https://www.swisshealthweb.ch/de/verlag/impressum/", "https://www.swisshealthweb.ch/de/verlag/datenschutz/", "https://www.swisshealthweb.ch/de/verlag/disclaimer/", "javascript:void()"]}